Navigation Links
Wake Pharma US to Present Series of Wound Healing Posters at 23rd SAWC
Date:4/15/2010

Wake Pharma US will present a series of seven wound care education posters at 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society. These posters overview the advanced science and clinical results behind the breakthrough healing gel Wound-Be-Gone, showcasing its fantastic results in a variety of clinical settings.

Elk Grove Village (PRWEB) April 15, 2010 -- Wake Pharma US announced today that seven posters detailing their revolutionary healing gel Wound-Be-Gone® will be presented at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS). These posters will detail impressive clinical evidence of this patented gel’s ability to help heal even the most severe and chronic wounds.

The largest event on wound healing in the country, the Annual Symposium on Advanced Wound Care and Wound Healing Society will be held at Gaylord Palms Hotel and Convention Center in Orlando, Florida, from April 17-20, 2010. Nearly a thousand posters were submitted to the symposium from renowned healing technology companies around the country, and just over three hundred were accepted by the Wound Healing Society; a series of seven posters from Wake Pharma US were accepted for display, illustrating the healing properties that their product Wound-Be-Gone® has when used on skin wounds.

These impressively well designed and technically detailed posters illustrate the profound positive impact that Wound-Be-Gone can have on even the most difficult to heal skin injuries. Says Wake Pharma US Medical Director Jeffrey Niezgoda, MD, “This extensive series of poster presentation of Wound-Be-Gone® clearly demonstrates the clinical, economic and patient benefits that can be derived from using Wound-Be-Gone®. This clinical data shows benefits in the treatment of a wide variety of wound types. As we continue to accumulate additional clinical
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Centice Corporation Releases a Two Part Whitepaper on its PASS Rx Pharmacy Quality Solution
2. Synergy between behavioral and pharmacologic interventions for ADHD
3. Pharmacists Play a Vital Role in Providing Immunizations in Their Communities
4. Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc.
5. Amistaff Launches RN Medical/Surgical & RN Pharmacology Exams Using New Validation Process Focused on Improving Quality of Patient Care
6. PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP
7. BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now
8. New Book Reviews Core Competencies for Pharmacy Leaders
9. Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
10. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results
11. Astellas Responds to OSI Pharmaceuticals Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Wake Pharma US to Present Series of Wound Healing Posters at 23rd SAWC
(Date:9/4/2015)... Valley Forge, PA (PRWEB) , ... September 04, 2015 , ... ... mold growth in and around the home is quite common. Mold can grow anywhere ... as areas around leaking pipes. Checking for excessive moisture and water in the home ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy SEAL who was ... Ironman World Championships in Kona on October 10th. , Mike is running the race ... through combat and the cutting-edge treatments that restore their quality of life. ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... The ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are ... take great pride in the quality of our ophthalmology residency program. Our faculty places ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC ... first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The ... and feature 30 cottage or “pocket” homes. In this community, adults will live ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal ... under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best ... Information Services, Inc. (AIS), will detail which deals are attracting the most government ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... to a tendon can signal an end to their ... in part by University of Southern California (USC) School ... within the adult tendon that have stem-cell characteristicsincluding the ... was able to isolate these cells and regenerate tendon-like ...
... STANFORD, Calif. - Researchers at the Stanford University School ... aglow tumor cells within living animals. Their goal is ... treatment of cancer and other diseases. , The probe,s ... - protein-destroying enzymes - that run amok in cancerous ...
... the National Press,Club,s 10th Annual 5K race today, which ... & F in Washington, Weiner Public News was first ... and op-ed writing,division of Robert Weiner Associates Public Affairs ... 100 papers since Weiner left the White,House in 2001 ...
... monitor eyesight carefully , , SATURDAY, Sept. 8 (HealthDay ... eyesight problems, which can appear gradually and worsen over ... properly monitored, eyesight deterioration can lead to other long-term ... eye exams every year. Changes in vision will not ...
... 7 Rocky Vista,University College of Osteopathic ... colleges of osteopathic medicine in the United ... in Colorado, has been granted provisional,accreditation from ... Accreditation (AOA-COCA). The provisional accreditation,will allow the ...
... to offset higher material prices. ... million in the year., ST. LOUIS, Sept. 7 ... net income increased 38,percent to $869,000, or 11 cents per ... or 8 cents per share, for the fourth,quarter last year. ...
Cached Medicine News:Health News:USC researcher identifies stem cells in tendons that regenerate tissue in animal model 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 3Health News:Weiner Public News First Media Team at National Press Club 5K 2Health News:Poor Senior Vision Often a Window on Disease 2Health News:Colorado Medical School Receives Provisional Accreditation 2Health News:Colorado Medical School Receives Provisional Accreditation 3Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 2Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 3Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 4Health News:Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006 5
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
(Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: